Solid leadership is critical to the success of a world-class institution like Joslin.
Joslin's Board of Trustees is made up of local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.
Joslin's Board of Trustees works closely with the Joslin executive staff. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge — the hallmark of this one-of-a-kind Center.
Ralph James, Chairperson of the Joslin Board of Trustees is Executive Director of External Relations at Harvard Business School, responsible for development and alumni relations activities for HBS.
Michael Astrue is the former Commissioner of Social Security (2007-2013). The Social Security Administration is an independent federal agency headquartered in suburban Baltimore with over 62,000 employees nationwide. As commissioner, Astrue reported directly to President Obama. [more]
John J. Cook, Jr., Counsel, Seaward Management. John joined Seaward in March 1999 and was a Managing Director through 2013. Prior to this he was President of UAM Investment Services for five years. [more]
Jim Geraghty is Entrepreneur-in-Residence at Third Rock Ventures. Having helped Genzyme launch rare disease therapies around the world, Jim assists the firm in creating companies focused on rare genetic diseases and supports existing portfolio companies in related spaces. [more]
Roberta Herman M.D. was, until July 2013, was the Chief Operating Officer for Harvard Pilgrim Health Care, one of New England’s largest non-profit managed health care organizations, providing care and coverage to over one million members throughout Massachusetts, Maine, and New Hampshire. [more]
Jessica Hopfield, Ph.D. -Vice Chairperson of the Joslin Board of Trustees -is a former partner of McKinsey & Company in their Global Pharmaceutical practice. While at McKinsey from 1995-2009, Ms. Hopfield served clients across pharmaceutical, biotech, medical device and consumer industries with a focus on strategy formulation, R&D management and marketing. [more]
Fred Keeton is Vice President of External Affairs and Chief Diversity Officer for Caesars Entertainment, the world's largest gaming-entertainment company. In this role, he oversees operationalizing diversity and inclusion in Human Resources, Supplier Sourcing, Community Reinvestment, Design and Construction, Marketing, innovation and continuous improvement. [more]
Ann Lagasse is owner of Lagasse Real Estate LLC a real estate development, leasing and management company. For twenty-five years she and her husband, Chuck, have been instrumental in the revitalization and restoration of the Newburyport historic downtown. Today their company is developing and managing mixed-use projects throughout NE. [more]
James Peterson served as CEO of Haemonetics Corporation, and after retirement has worked to bring new technologies into reality to improve the quality of life of people with diabetes. In the process he was advisor to a private equity group on their diabetes investments, founded an insulin pump company for people with type 1 diabetes, and founded an insulin infusion company for people with type 2 diabetes. [more]
Geoffrey S. Rehnert is the Co-Chief Executive Officer and co-founder of Audax Group, a leading middle market private equity and private debt firm. Prior to founding Audax Group, Mr. Rehnert was a General Partner and Managing Director of Bain Capital, Inc., which he helped to start in 1984. [more]
Arthur H. Rubenstein, MBBCh is Professor, Department of Medicine, Division of Endocrinology at the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania. Previously, Dr. Rubenstein was the Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine from September 2001 to July 2011. [more]
Mark E. Russell is Vice President of Engineering, Technology and Mission Assurance for Raytheon Company. He assumed the position in July 2008, and was elected a company officer in June 2008. Russell guides the company’s vision and provides corporate leadership in the strategic areas of technology and research, engineering, operations, performance excellence, programs security, Raytheon Six Sigma™ and Mission Assurance. He is responsible for 45,000 world-class people working on more than 8,000 programs. [more]
Stefany Shaheen is the Chief Operating Officer of Good Measures, a provider of Registered Dietitian Nutritionist (RDN) services. Prior to Good Measures, Shaheen owned and operated a management and communications consulting practice working with private and non-profit organizations with a focus on helping organizations navigate challenging transitions. [more]
Richard Smith is the Co-Chairman of the Richard and Susan Smith Family Foundation. Dick has held a wide range of influential business and civic positions over the course of his career. He was the former Chairman of the Board and CEO of Harcourt General, the Neiman Marcus Group and the GC Companies. He has held directorships at the First National Bank of Boston, Liberty Mutual Insurance Company and Wang Laboratories. [more]
John L. Brooks III, President and CEO, Joslin Diabetes Center, a well-known life sciences executive, was appointed President and Chief Executive Officer in March 2011, having previously served as Chairman of the Joslin Board of Trustees. [more]
Robert A. Gabbay, M.D., Ph.D., FACP, Chief Medical Officer, has over 35 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center. [more]
Charles Hood is the President of Charles H. Hood Foundation. His grandfather founded H.P.Hood & Sons and his father was the former CEO and President. During his tenure on the Joslin Board, he served as Vice Chair, an Incorporator, Treasurer and on various Trustee committees. [more]
Patrick O'Neill has served as senior executive for numerous mining companies located throughout the world. In 1982, he became an independent mining consultant until his retirement in 2005. Patrick has served on numerous civic and professional organizations. During his tenure at Joslin, he served as Board Chair and Chair of the Committee overseeing the construction of the Howard F. Root wing of Joslin. [more]
Ken Quickel, M.D. is President Emeritus of the Joslin Diabetes Center. He served as CEO from 1987-2000 and again from 2008-2010. He was a staff physician at Beth Israel Deaconess Medical Center, a lecturer at Harvard Medical School, a trustee of both Beth Israel Deaconess Medical Center and CareGroup and an Overseer of Brigham & Women’s Hospital. [more]
Page last updated: March 27, 2015